Our Insights

Article

Innovative pharma contracts: When do value-based arrangements work?

– Many are exploring alternatives to traditional ‘per pill’ arrangements underlying reimbursement. This holds implications for pharma manufacturers.

Special collection

Collection

Biopharma Frontiers:
What the future holds for the industry

Industry leaders and key stakeholders offer perspectives to inspire discussion and constructive debate.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights

Article

Elevating the impact of medical affairs in Japan

– Recent research sheds light on the value of the medical channel and what it takes to have a high-performing medical-affairs organization.
Article

Biopharma valuations—onward and upward?

– Companies focused on biopharma have done well in capital markets. A closer look at performance helps explain why.
Article

A 360-degree approach to patient adherence

– When patients don’t follow treatment regimens, outcomes worsen and costs rise. An insights-driven approach can help.
Video

Building trust-based relationships in pharma

– Belén Garijo, member of the executive board of Merck and CEO of Merck Healthcare, touches on the industry’s outlook... and how her company is positioning itself for the future.
Interview

Leadership and strategic innovation in pharma

– The CEO of Shire explains how he’s repositioning the company and gearing up for more change.
Video

Using data and technology to improve healthcare ecosystems

– A Verily Life Sciences executive explains how the company targets better patient outcomes by harnessing analytics, machine learning,... and other digital tools.
Report

European healthcare—a golden opportunity for private equity

– A review of investment opportunities in Europe
Interview

What talent management can do to shape next-generation pharma leaders

– A Sanofi executive discusses his company’s leadership-development programs and approach to building employee capabilities amid... rapid change.
Article

What’s next for pharma in emerging markets?

– Succeeding in emerging markets has been a challenging undertaking for multinational pharma companies, but those that adapt their... end-to-end model for emerging markets could well thrive.
Article

Winning in Nigeria: Pharma’s next frontier

– Amid the country’s downturn, should companies still be looking here for growth? Yes—and we can learn five lessons from players... getting it right today.
Article

Implementing a two-invoice system in China’s MedTech market

– The country is rolling out a new approach to pharmaceutical distribution. What can medical-device companies expect, and how should... they prepare?

Connect with our Pharmaceuticals & Medical Products Practice